CD40-targeted peptide proposed for type 1 diabetes therapy lacks relevant binding affinity to its cognate receptor

被引：0
|
作者：
Philippe P. Pagni
Anitra Wolf
Mauro Lo Conte
Ronald Yeh
Guangsen Fu
Fa Liu
Matthias von Herrath
Ken Coppieters
机构：
[1] Novo Nordisk Research Center,
[2] Novo Nordisk A/S Research Projects,undefined
来源：
Diabetologia | 2019年 / 62卷
关键词：
CD40; CD40L; Type 1 diabetes;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1727 / 1729
页数：2
相关论文
共 50 条
  • [1] CD40-targeted peptide proposed for type 1 diabetes therapy lacks relevant binding affinity to its cognate receptor
    Pagni, Philippe P.
    Wolf, Anitra
    Lo Conte, Mauro
    Yeh, Ronald
    Fu, Guangsen
    Liu, Fa
    von Herrath, Matthias
    Coppieters, Ken
    DIABETOLOGIA, 2019, 62 (09) : 1727 - 1729
  • [2] CD40-targeted peptide proposed for type 1 diabetes therapy lacks relevant binding affinity to its cognate receptor. Reply to Pagni PP, Wolf A, Lo Conte M et al [letter]
    Gisela M. Vaitaitis
    Michael H. Olmstead
    Dan M. Waid
    Jessica R. Carter
    David H. Wagner
    Diabetologia, 2019, 62 : 1730 - 1731
  • [3] CD40-targeted peptide proposed for type 1 diabetes therapy lacks relevant binding affinity to its cognate receptor. Reply to Pagni PP, Wolf A, Lo Conte M et al [letter]
    Vaitaitis, Gisela M.
    Olmstead, Michael H.
    Waid, Dan M.
    Carter, Jessica R.
    Wagner, David H., Jr.
    DIABETOLOGIA, 2019, 62 (09) : 1730 - 1731
  • [4] A CD40-targeted peptide controls and reverses type 1 diabetes in NOD mice
    Vaitaitis, Gisela M.
    Olmstead, Michael H.
    Waid, Dan M.
    Carter, Jessica R.
    Wagner, David H., Jr.
    DIABETOLOGIA, 2014, 57 (11) : 2366 - 2373
  • [5] A CD40-targeted peptide controls and reverses type 1 diabetes in NOD mice
    Gisela M. Vaitaitis
    Michael H. Olmstead
    Dan M. Waid
    Jessica R. Carter
    David H. Wagner
    Diabetologia, 2014, 57 : 2366 - 2373
  • [6] Evaluation of soluble CD40L in children with type 1 diabetes mellitus and its relation to diabetes associated vasculopathy
    Hodeib, Mahmoud
    Maebed, Mohamed H.
    Abougabal, Khadiga
    Etman, Ghada S.
    EGYPTIAN JOURNAL OF PEDIATRIC ALLERGY AND IMMUNOLOGY, 2021, 19 (02): : 105 - 112
  • [7] Unique "delta lock" structure of telmisartan is involved in its strongest binding affinity to angiotensin II type 1 receptor
    Ohno, Kazuki
    Amano, Yasushi
    Kakuta, Hirotoshi
    Niimi, Tatsuya
    Takakura, Shoji
    Orita, Masaya
    Miyata, Keiji
    Sakashita, Hitoshi
    Takeuchi, Makoto
    Komuro, Issei
    Higaki, Jitsuo
    Horiuchi, Masatsugu
    Kim-Mitsuyama, Shokei
    Mori, Yutaka
    Morishita, Ryuichi
    Yamagishi, Sho-ichi
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2011, 404 (01) : 434 - 437
  • [8] Binding of avian ovomucoid to Shiga-like toxin type 1 and its utilization for receptor analog affinity chromatography
    Miyake, M
    Utsuno, E
    Noda, M
    ANALYTICAL BIOCHEMISTRY, 2000, 281 (02) : 202 - 208
  • [9] Addition of glucagon-like peptide-1 receptor agonist therapy to insulin in C-peptide-positive patients with type 1 diabetes
    Kuhadiya, Nitesh D.
    Prohaska, Ben
    Ghanim, Husam
    Dandona, Paresh
    DIABETES OBESITY & METABOLISM, 2019, 21 (04): : 1054 - 1057
  • [10] Glucagon-like peptide-1 receptor agonists as add-on therapy to insulin for type 1 diabetes mellitus
    Tan, Xinrui
    Pan, Xiongfeng
    Wu, Xiaochuan
    Zheng, Songjia
    Chen, Yuyao
    Liu, Donghai
    Zhang, Xingxing
    FRONTIERS IN PHARMACOLOGY, 2023, 14
12345